Preparation method of magnetic control piezoelectric short fiber orientation microsphere support
By adding magnetic nanoparticles and piezoelectric nanoparticles to the microspheres to create a magneto-controlled piezoelectric short fiber oriented microsphere scaffold, the problems of non-invasive piezoelectric effect and directed cell growth were solved, achieving efficient repair of peripheral nerve injury.
Patent Information
- Application Number
- CN202411090007.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-09
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-08-09
AI Technical Summary
Existing technologies struggle to achieve non-invasive, in vivo piezoelectric effects, and the disordered distribution of microspheres prevents the guidance of directional cell growth, resulting in poor repair outcomes for peripheral nerve damage.
A magnetically controlled piezoelectric short fiber oriented microsphere scaffold is used. By adding magnetic nanoparticles and piezoelectric nanoparticles to the microspheres, an external magnetic field is used to induce a piezoelectric effect on the short fibers, thereby achieving directional alignment and cell guidance.
It promotes peripheral nerve regeneration and repair, simplifies the operation process, realizes non-invasive magnetoelectric conversion function, and improves the efficiency and accuracy of nerve injury repair.
Smart Images

Figure CN118988182A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of medical biomaterials implantable in human body in tissue engineering and regenerative medicine, and specifically relates to a preparation method and application of a magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve damage. Background Art
[0002] Peripheral nerve injury is a common disease in clinical practice. The nerve bundle is the basic unit of the peripheral nerve, which is composed of nerve fibers, Schwann cells, blood vessels and surrounding connective tissue. Compared with the central nervous system, the peripheral nervous system has a significant regenerative capacity after injury. Schwann cells in the peripheral nervous system are a type of regenerative cells that can maintain their repair ability after nerve injury. When the injury occurs, the distal nerve region of the injured site undergoes Wallerian degeneration and creates a possible microenvironment for subsequent axon regeneration. After dedifferentiation, Schwann cells proliferate and extend longitudinally to form Büngner bands, which help guide axon regeneration; they also secrete various cytokines, growth factors, neurotrophic factors and extracellular matrix molecules to promote neuronal survival and axon regeneration. Under the action of various factors, the injured neurons quickly activate the intrinsic program and regenerate to their distal targets. After contacting the regenerating axons, Schwann cells regenerate axons and repel infiltrating macrophages, completing the peripheral nerve repair process.
[0003] However, severe peripheral nerve damage is difficult to recover on its own, and will lead to permanent neurological function loss without surgery or drug intervention, such as loss of motor function, chronic pain and muscle atrophy. At present, the "gold standard" for treating peripheral nerve damage is autologous transplantation, but this method has defects such as insufficient donor nerves and infection of the donor site, and it is difficult to meet the needs of long-distance defects, resulting in secondary damage and loss of sensation in the donor site, thus limiting its clinical application. Therefore, artificial nerve grafts have become a research hotspot. However, the microenvironment created by the existing nerve grafts cannot fully meet the requirements of peripheral nerve regeneration, so their regeneration effect is still not as good as that of autologous nerve grafts, and they cannot meet clinical needs well. There is an urgent need to further improve the performance of the grafts.
[0004] The ideal tissue engineering nerve graft should be a composite of a biological scaffold with its internal nutritional factors and bionic structures. The bionic structure can provide a suitable microenvironment for the migration, proliferation and functionalization of nerve cells, and provide contact guidance for the directional growth of axons to improve the accuracy of nerve alignment. However, due to the complexity of natural nerve structures, the preparation of artificial nerve grafts with micro-nano nerve-like structures remains a huge challenge. In recent years, various bionic microspheres with unique structures and properties have been developed as cell carriers and drug delivery carriers. As an injectable scaffold with good signal delivery function, microspheres can be injected into irregular defective or damaged tissues, thereby shortening the recovery time several times compared to traditional 3D scaffold surgery. So far, microspheres of different shapes and structures have been used in tissue engineering research.
[0005] Short fibers can well simulate the physical microenvironment of nerve tissue, provide a suitable extracellular environment for cell growth, and are conducive to the growth of nerve cells. Such as solid core fibers, nanofibers, hollow fibers and nanofibers. These fibers can well simulate the nano-to-microscopic morphology and structure of fiber components in the ECM of nerve tissue and are widely used in the field of tissue regeneration. The short fibers obtained after homogenization can well simulate the ECM-like structure, providing a higher possibility for tissue repair. The nano-short fiber microspheres have a large specific surface area, which makes them have a higher drug loading efficiency. Therefore, short fibers and microspheres combine the advantages of both, not only can they simulate the simulated ECM-like morphology, but also can be injected for the treatment of traumatic diseases. Microspheres have a high surface area to volume ratio, providing sufficient space for cell growth. In addition, microspheres with functional structures (loaded drugs, core-shell) are easy to prepare and can effectively enhance the delivery of cells and bioactive molecules. Therefore, as a new type of injectable scaffold, functional nano-short fiber microspheres have attracted widespread attention in recent years and are expected to play a promoting role in the repair of peripheral nerve defects.
[0006] Studies have found that various external physical stimuli such as electricity, magnetism, light and sound can affect biological activities and regulate cell behavior. Among them, magnetic stimulation shows advantages over other types of stimulation. Magnetic actuation has great advantages in non-invasive treatment, non-contact controllability, and high penetration ability. It has been widely used in the field of tissue engineering, such as cell 3D printing and inducing stem cell differentiation. Under low-frequency magnetic fields, the movement of magnetic nanoparticles (MNPs) can induce magnetic mechanical drive of loaded magnetic materials, which can realize non-invasive treatment and magnetically controlled drug delivery in the biomedical field. Electrical signals are considered to be factors that play an important role in promoting nerve cells during neurogenesis and are also an important consideration in the design of neural repair scaffolds. Therefore, a class of piezoelectric materials with piezoelectric effect has become a research hotspot in tissue engineering. Piezoelectric biomaterials can generate electric fields (EF) when subjected to stress (deformation). Therefore, they can improve tissue repair and regeneration by stimulating signal pathways. A series of studies have shown that the potential induced by piezoelectric polymers and ceramics may stimulate cellular responses and biological activities of hard tissues, and have great potential in non-invasive treatment of nerve regeneration. Piezoelectric scaffolds have been used as an effective material for repairing defective nerves. Therefore, short fibers added with MNPs (such as Fe3O4, Fe2O3) and piezoelectric particles (such as BaTiO3, ZnO) are prepared. MNPs can exert mechanical force on the piezoelectric particles on the fibers under the regulation of the external magnetic field, causing them to produce a piezoelectric effect, thereby stimulating and regulating the surrounding cells and tissues accordingly. Summary of the invention
[0007] The purpose of the present invention is to provide a preparation method and application of a magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, so as to realize the magnetically controlled generation of piezoelectric effect. It solves the problems that the non-invasive and non-invasive in vivo generation of piezoelectric effect is difficult to achieve in the prior art, and the disordered distribution of microspheres cannot guide the directional growth of cells. The microspheres of the present invention can respond to the external magnetic field through the magnetic nanoparticles carried by themselves, and act on the BaTiO3 piezoelectric ceramic particles on the short fibers, so that the microspheres produce piezoelectric effect. The microspheres and the short fibers inside the microspheres can be arranged in a certain orientation under the action of the external magnetic field. Such anisotropic topological structure can well guide the elongation and migration of Schwann cells and guide the extension of axons, thereby accelerating the speed of peripheral nerve regeneration and repair. Compared with traditional microsphere scaffolds, the invention promotes the directional elongation of broken nerves through anisotropic topological structures, and innovatively uses magnetic nanoparticles to respond to magnetic fields and generate mechanical forces to act on the same short fibers. Piezoelectric particles, thereby generating the phenomenon of magnetically controlled piezoelectricity, avoids the inability of traditional piezoelectric materials to apply pressure normally after surgery to produce piezoelectric effects. The magnetoelectric method is simple and easy to implement. It only requires placing a magnet near the magnetoelectric microspheres, so that the microspheres are subjected to an external magnetic field and generate a certain mechanical force acting on the piezoelectric nanoparticles, and then the piezoelectric phenomenon can be generated. Therefore, in view of the lack of relevant products in the market, the present invention is of great application value.
[0008] In order to solve the above existing problems, the present invention adopts the following technical solutions:
[0009] A method for preparing a magnetron piezoelectric short fiber oriented microsphere scaffold comprises the following steps:
[0010] (1) Surface modification of magnetic nanoparticles and piezoelectric nanoparticles to improve particle dispersibility, degradability and biocompatibility;
[0011] (2) Using nanofiber preparation technology to prepare biomaterial-based micro-nano long fibers with nanometer diameters and loaded with magnetic nanoparticles and piezoelectric nanoparticles;
[0012] (3) The long fibers are evenly dispersed in the solution, and short fibers with a length distribution within a certain range are prepared using micro-nano processing technology;
[0013] (4) dispersing a certain mass of short fibers in a microsphere preparation solution;
[0014] (5) using microsphere preparation technology to prepare the short fiber solution into magnetically controlled piezoelectric short fiber microspheres, and using a cross-linking method to separate the microspheres from the liquid phase;
[0015] (6) The formed microspheres are filtered through a sieve, dispersed in a solution after washing, and a magnetronized piezoelectric short fiber microsphere scaffold is obtained.
[0016] Preferably, the diameter of the biomaterial-based micro-nano long fibers is 10 nm-500 μm.
[0017] Preferably, the main body of the tissue engineering graft in the present invention is preferably one or more of spinnable materials such as chicken ovalbumin (OVA), polycaprolactone (PCL), silk fibroin (SF), chitosan (CS), etc.
[0018] Preferably, the concentration of the piezoelectric nanoparticles in step (1) is 0-2 g / mL, and the concentration that can produce the maximum piezoelectric effect is screened out for subsequent operations.
[0019] Preferably, the concentration of the magnetic nanoparticles in step (1) is 0-2 g / mL, and the concentration that can produce the best piezoelectric effect by responding to the magnetic field is screened out for subsequent operations.
[0020] Preferably, in the nanofiber preparation technology in step (2), the nanofiber preparation process undergoes the preparation of a biomaterial solution, ultrasonic vibration to evenly disperse the magnetic nanoparticles and piezoelectric nanoparticles in the biomaterial solution, a nanofiber preparation process, and removal of an organic solvent.
[0021] Preferably, the concentration of the short fibers in step (3) is 0.1-1 g / mL; the time for the short fiber preparation process is 1-20 min, and the short fiber length is selected to prepare microspheres of appropriate size.
[0022] Preferably, the magnetic nanoparticles in step (1) are one or more of Fe, Co, Ni monomers and their alloy nanoparticles, metal oxide nanoparticles; the piezoelectric nanoparticles are ZnO, perovskite (SrTiO3, BaTiO3, Bi 0.5 Na 0.5 TiO3, KNbO3 or ZnSnO3), BiOX (X = Cl, Br, I, etc.), one or more thereof; the concentration range of the nanoparticles is 0.1-200 mg / mL.
[0023] Preferably, the surface modification method in step (1) is one or more of inorganic metal modification (Au, Ag, etc.), organic small molecule modification (oleic acid, tannic acid, sodium oleate, dodecylamine, γ-cyclodextrin, etc.), high molecular polymer modification (polydopamine, chitosan, dextran, polyvinyl alcohol, polyvinyl pyrrolidone, polyethylene glycol, polyacrylic acid, polyethyleneimine, etc.), silanization modification, etc.; the dopamine modification concentration is 2 mg / mL, and the chitosan modification concentration is 10-20 mg / mL;
[0024] Preferably, the nanofiber preparation method in step (2) is one or more of electrospinning technology, microfluidics technology, 3D printing technology, and near-field direct writing technology; wherein the electrospinning parameters are: flow rate of 5-25 μL / min, voltage of 10-25 kV, receiving distance of 10-20 cm, receiving mode of flat plate receiving or drum collection, drum receiving speed of 1000-2000 rpm, spinning time of 6-12 h; the microfluidics technology parameters are: propulsion speed of 1-300 μL / min; the 3D printing technology parameters are: print head temperature of 5-15 ° C, printing platform temperature set to -10 ° C, printing speed of 5-20 mm / s; the near-field direct writing parameters are: needle inner diameter of 0.5 mm, melt thrust of 0.2 MPa, fiber spacing of each sample set to 1.0 mm, receiving distance of 3-6 cm, receiving plate moving speed of 3-7 mm / s, melt temperature of 100-150 ° C;
[0025] Preferably, the biomaterial in step (2) is one or more of natural biomaterials (collagen, fibrin, gelatin, silk fibroin, ovalbumin, chitosan, cellulose, hyaluronic acid, alginate, etc.) and synthetic biomaterials (polycaprolactone, polyvinyl pyrrolidone, polyethylene glycol, polylactic acid, etc.);
[0026] Preferably, the solution in which the long fibers are dispersed in step (3) is one of PBS or physiological saline; the method for preparing the short fibers is one or more of grinding, homogenization, microscissor shearing, liquid nitrogen brittle breaking, freeze drying and then crushing; the length distribution range of the short fibers is 5-150 μm, and the fiber diameter distribution range is 20-500 nm, the length distribution range is determined according to the time length of the short fiber preparation method, and the diameter distribution range is determined according to factors such as the flow rate, rotation speed, and voltage of the fiber preparation method;
[0027] Preferably, the microsphere preparation solution in step (4) is one or more of N,N-dimethylformamide (DMF), hexafluoroisopropanol (HFIP), formic acid, chloroform (CHCl3), acetic acid, gellan gum solution, sodium alginate solution and oil containing surfactant; in the microsphere collection method, the collection solution is Ca 2+ solution, formaldehyde, glutaraldehyde and other solutions; the gellan gum solution concentration is 0.1-1% (w / v), the sodium alginate solution concentration is 0.5-5g / mL, Ca 2+ The concentration is 0.1-1M, and the surfactant is one of Span and Tween;
[0028] Preferably, the microsphere preparation technology in step (5) is one of spray drying, electrospraying, water-in-oil emulsification, microfluidics, freeze drying, emulsion-solvent evaporation, phase separation and reverse suspension crosslinking; the crosslinking method is ionic crosslinking (Ca 2+ The diameter of the magnetron piezoelectric microspheres is distributed in the range of 10nm-500μm, and magnetron piezoelectric microspheres with different diameters can be prepared according to actual needs.
[0029] Preferably, in the microsphere washing method in step (6), the washing liquid used is one or more of anhydrous ethanol, 75% ethanol, isopropanol, acetone, etc.; the external magnetic field driving source of the magnetron piezoelectric microspheres is a static magnetic field or an alternating magnetic field (10mT-2T) with a magnetic field intensity distribution ranging from low intensity to high intensity.
[0030] Beneficial effects of the present invention:
[0031] (1) The present invention prepares electrospun fibers into short fibers, which can better simulate ECM-like structures, facilitate the three-dimensional growth of cells, avoid problems such as cell non-adhesion and difficulty in proliferation caused by different physical environments, and are closer to the real microenvironment for cell growth;
[0032] (2) The present invention prepares short fibers into microspheres, which can achieve in vivo delivery of ECM-like structures;
[0033] (3) The present invention adds magnetic nanoparticles and piezoelectric particles to the microspheres, which can realize remote control of the movement of the microspheres and realize the function of non-invasive magnetoelectric conversion under the regulation of the external magnetic field, thereby promoting nerve damage repair and realizing personalized non-invasive nerve damage repair;
[0034] (4) The magnetron controlled piezoelectric short fiber oriented microspheres of the present invention can be encapsulated into nerve guide catheters to promote the repair of peripheral nerve defects. They can also be used as injectable magnetron piezoelectric functional stents for wound repair of various tissues and organs.
[0035] (5) The magnetically controlled piezoelectric short fiber oriented microsphere scaffold for tissue repair prepared by the present invention has good biocompatibility, can well load magnetic nanoparticles and piezoelectric nanoparticles, can be used for remote wireless magnetic control to produce piezoelectric effect, and is used for various tissue repairs;
[0036] (6) The preparation process of the present invention is simple, the material source is easily available, and the cost is low. It can be used as an ideal biofunctional material and has good potential application in the field of peripheral nerve regeneration. The present invention can be expanded to the fields of spinal cord nerve repair, skin repair, bone tissue repair, etc., and has good potential application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] Figure 1 One of the methods for surface modification of magnetic nanoparticles and piezoelectric nanoparticles: schematic diagram of dopamine modification;
[0038] Figure 2 This is the SEM image of magnetic nanoparticles after modification;
[0039] Figure 3 TEM image of piezoelectric particles after modification;
[0040] Figure 4 is the SEM image of long nanofibers;
[0041] Figure 5 is the SEM image of short nanofibers;
[0042] Figure 6 This is the optical microscope image of the magnetron piezoelectric microsphere;
[0043] Figure 7 This is the SEM image of the magnetron piezoelectric microsphere;
[0044] Figure 8 Fluorescence image of co-culture of magnetically controlled piezoelectric microspheres and Schwann cells;
[0045] Fig. 9 It is a flow chart of the preparation method of the present invention. DETAILED DESCRIPTION
[0046] The present invention is further explained below in conjunction with examples. The following examples are only used to illustrate the present invention, but are not intended to limit the scope of practice of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms also fall within the scope defined by the appended claims of the present application.
[0047] Example 1
[0048] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0049] (1) Dissolve 1.5 g OVA powder and 0.2 g PEO in 10 mL hexafluoroisopropanol (HFIP) / formic acid (3:1) mixed solution, add 20 mg Fe3O4 and ZnO particles respectively, and mix thoroughly by ultrasonic vibration;
[0050] (2) The OVA solution was prepared into an electrospinning fiber membrane by using electrospinning technology; the electrospinning parameters were: flow rate 10 μL / min, voltage 20 kV, receiving distance d=15 cm, roller collection, and rotation speed 1500 rpm;
[0051] (3) 1 g of electrospun fibers were placed in a 1.5 mL centrifuge tube, and the electrospun membrane treated with anhydrous ethanol was ground into short fibers using a homogenizer for 10 min; 0.6 g of gellan gum was dissolved in 100 mL of deionized water to prepare a 0.6% w / v gellan gum solution; and 1 g of the ground short fibers was dispersed in 10 mL of the gellan gum solution;
[0052] (4) Microspheres were prepared by microfluidic technology using a dual-channel microinjection pump, wherein the dispersed phase was OVA short fibers and gellan gum solution, and the mobile phase was a paraffin oil solution containing 5% wt span80; the receiving device was a mixed solution of equal volumes of 1 M CaCl2 solution and paraffin oil; the flow rate ratio of the microfluidic control was 1:1000;
[0053] (5) The prepared microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetron piezoelectric microspheres;
[0054] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
[0055] Example 2
[0056] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0057] (1) Dissolve 1 g of PCL particles in 10 mL of hexafluoroisopropanol (HFIP) solution, add 0.2 g of Fe3O4 and BaTiO3 particles respectively, and mix thoroughly by ultrasonic vibration;
[0058] (2) PCL solution was prepared into fibers using 3D printing technology: PCL solution was placed in a 5 mL syringe and extruded through a needle with an inner diameter of 0.26 mm at a printing speed of 15 mm / s. A low-temperature well printing platform was used to quickly solidify the extruded filament and keep the printed scaffold solidified. The temperature of the print head was set to 8°C and the temperature of the printing platform was set to -10°C.
[0059] (3) 1 g of PCL fiber was placed in a 1.5 mL centrifuge tube, and the centrifuge tube was placed in liquid nitrogen for 30 min. The fiber treated with anhydrous ethanol was ground into short fibers using the liquid nitrogen brittle fracture method, and the grinding time was 10 min;
[0060] (4) Microspheres were prepared using a dual-channel microinjection pump and microfluidic technology, wherein the dispersed phase was PCL short fibers and sodium alginate solution, and the mobile phase was a decanol solution containing 5% span80; the receiving device was a solution prepared by mixing equal volumes of 1 M CaCl2 and decanol; the flow rate ratio of the microfluidic was 1:1000;
[0061] (5) The microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetronized piezoelectric microspheres;
[0062] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
[0063] Example 3
[0064] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0065] (1) 3 g of chitosan (CS) powder and 0.2 g of sodium alginate were dissolved in 100 mL of acetic acid (2%) to prepare a 3% chitosan solution. 20 mg of Fe3O4 and BaTiO3 particles were added to 10 mL of the chitosan solution respectively and the mixture was thoroughly mixed by ultrasonic vibration.
[0066] (2) The CS solution was prepared into an electrospinning fiber membrane by using electrospinning technology; the electrospinning parameters were: flow rate 15 μL / min, voltage 20 kV, receiving distance d=15 cm, drum collection, and rotation speed 2000 rpm;
[0067] (3) 1 g of electrospun chitosan fiber was placed in a 1.5 mL centrifuge tube, and the electrospun membrane treated with anhydrous ethanol was ground into short fibers using a grinder for 10 min;
[0068] (4) preparing microspheres by electrospraying, spraying the fiber solution into a metal plate through a nozzle to form microsphere particles; applying an 8 kV electrostatic potential on an electrostatic spray device to generate droplets, collecting the droplets in a 10% CaCl2 solution, and rapidly crosslinking to form microspheres;
[0069] (5) The microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetronized piezoelectric microspheres;
[0070] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
[0071] Example 4
[0072] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0073] (1) Dissolve 1.5 g OVA and 0.2 g PEO in a hexafluoroisopropanol (HFIP) / formic acid (3:1) solution, add 10 mg Fe2O3 and ZnO particles respectively, and mix thoroughly by ultrasonic vibration;
[0074] (2) The OVA solution was prepared into an electrospun fiber membrane using 3D printing technology: the OVA solution was placed in a 5 mL syringe and extruded through a needle with an inner diameter of 0.26 mm at a printing speed of 20 mm / s. A low-temperature well printing platform was used to quickly solidify the extruded filament and keep the printed scaffold solidified. The temperature of the print head was set to 8°C and the temperature of the printing platform was set to -10°C.
[0075] (3) 1 g of OVA fiber was placed in a 1.5 mL centrifuge tube, and the electrospun membrane treated with anhydrous ethanol was ground into short fibers using a homogenizer for 10 min.
[0076] (4) Microspheres were prepared using the O / W emulsification-solvent evaporation method. 1 g of the prepared short fibers were dispersed in 10 mL of an aqueous phase containing sodium alginate. The oil phase was slowly added and the liquid was stirred at a speed of 2000 rpm. 2+ Ion cross-linked extraction microspheres;
[0077] (5) The microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetronized piezoelectric microspheres;
[0078] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
[0079] Example 5
[0080] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0081] (1) Dissolve 0.3 g CS in 2% acetic acid solution to prepare 10 mL 3% CS solution, add 20 mg Fe3O4 and 10 mg ZnO particles respectively, and mix thoroughly by ultrasonic vibration;
[0082] (2) The CS solution was prepared into an electrospinning fiber membrane by using electrospinning technology; the electrospinning parameters were: flow rate 25 μL / min, voltage 20 kV, receiving distance d = 15 cm, and flat plate collection;
[0083] (3) 1 g of electrospun CS fiber was placed in a 1.5 mL centrifuge tube, and the electrospun membrane treated with anhydrous ethanol was ground into short fibers using a homogenizer for 10 min.
[0084] (4) Using a microsphere collector, microspheres were prepared by electrostatic spraying, wherein the dispersed phase was CS short fibers and gellan gum solution, the mobile phase was a glycerol solution containing 5% span80; the receiving device was a solution prepared by mixing equal volumes of 1 M CaCl2 and glycerol; the flow rate ratio of the microfluidic was 1:1000;
[0085] (5) The microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetronized piezoelectric microspheres;
[0086] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
[0087] Example 6
[0088] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0089] (1) 15% silk fibroin (SF) and 2% PEO were dissolved in hexafluoroisopropanol (HFIP) / formic acid (3:1) solution, and 20 mg of Fe3O4 and BaTiO3 particles were added respectively, and the mixture was thoroughly mixed by ultrasonic vibration;
[0090] (2) OVA solution was prepared into electrospun fiber membrane using 3D printing technology: The silk protein solution was placed in a 5 mL syringe and extruded through a needle with an inner diameter of 0.26 mm at a printing speed of 18 mm / s. A low-temperature well printing platform was used to quickly solidify the extruded filaments and keep the printed scaffold solidified. The temperature of the print head was set to 8°C and the temperature of the printing platform was set to -10°C.
[0091] (3) 1 g of silk fibroin fiber was placed in a 1.5 mL centrifuge tube, and the centrifuge tube was placed in liquid nitrogen for 30 min. The electrospun membrane treated with anhydrous ethanol was ground into short fibers using the liquid nitrogen brittle fracture method, and the grinding time was 10 min;
[0092] (4) Microspheres were prepared using a dual-channel microinjection pump and microfluidic technology, wherein the dispersed phase was a silk fibroin short fiber and gellan gum solution, and the mobile phase was a paraffin oil solution containing 5% span80; the receiving device was a solution prepared by mixing equal volumes of 1 M CaCl2 and paraffin oil; the flow rate ratio of the microfluidic control was 1:1000;
[0093] (5) The microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetronized piezoelectric microspheres;
[0094] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
[0095] Example 7
[0096] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0097] (1) Dissolve 10 g PCL and 5 g silk fibroin (SF) in hexafluoroisopropanol (HFIP) solution, add 10 mg CoFe2O4 and 20 mg BaTiO3 particles respectively, and mix thoroughly by ultrasonic vibration;
[0098] (2) The PCL / SF solution was prepared into an electrospun fiber membrane using near-field direct writing technology; the inner diameter of the needle was 0.5 mm, the melt thrust was 0.2 MPa, the fiber spacing of each sample was set to 1.0 mm, the receiving distance was 4 cm, and the receiving plate moving speed was 5 mm / s.
[0099] (3) 1 g of PCL / SF fiber was placed in a 1.5 mL centrifuge tube, and the electrospun membrane treated with anhydrous ethanol was freeze-dried using freeze-drying technology, and then ground into short fibers;
[0100] (4) Microspheres were prepared using a dual-channel microinjection pump and microfluidic technology, wherein the dispersed phase was PCL / SF short fibers and alginate solution, and the mobile phase was a glycerol solution containing 15% span80; the receiving device was a solution prepared by mixing equal volumes of 1 M CaCl2 and glycerol; the flow rate ratio of the microfluidic control was 1:500;
[0101] (5) The microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetronized piezoelectric microspheres;
[0102] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
[0103] Example 8
[0104] A magnetically controlled piezoelectric short fiber oriented microsphere scaffold for treating peripheral nerve injury, the specific preparation of which includes the following steps:
[0105] (1) Dissolve 1 g PCL and 1 g PVDF in 10 mL hexafluoroisopropanol solution, add 10 mg Co3O4 particles, and mix thoroughly by ultrasonic vibration;
[0106] (2) The PCL solution was prepared into an electrospinning fiber membrane by electrospinning technology; the electrospinning parameters were: flow rate 10 μL / min, voltage 20 kV, receiving distance d=15 cm, drum collection, and rotation speed 1000 rpm;
[0107] (3) 1 g of electrospun fiber was placed in a 1.5 mL centrifuge tube, and the electrospun membrane treated with anhydrous ethanol was ground into short fibers using a homogenizer for 10 min;
[0108] (4) Microspheres were prepared using a dual-channel microinjection pump and microfluidic technology, wherein the dispersed phase was PCL short fibers and sodium alginate solution, and the mobile phase was a sunflower oil solution containing 5% span80; the receiving device was a solution prepared by mixing equal volumes of 1 M CaCl2 and sunflower oil; the flow rate ratio of the microfluidic was 1:1500;
[0109] (5) The microspheres were filtered through a mesh and treated with hot ethanol, and then dispersed in 5 mL of PBS solution to obtain magnetronized piezoelectric microspheres;
[0110] (6) When co-cultured with cells or applied in vivo, a magnetic field can be applied externally to remotely control the microspheres, so that the microspheres respond to the magnetic field to generate mechanical force, act on the piezoelectric material to produce a piezoelectric effect, and form an oriented microsphere array to guide the directional growth of new cells.
Claims
1. A method for preparing a magnetron piezoelectric short fiber oriented microsphere scaffold, characterized in that: The following steps are involved: (1) Surface modification of magnetic nanoparticles and piezoelectric nanoparticles to improve particle dispersibility, degradability and biocompatibility; (2) Using nanofiber preparation technology to prepare biomaterial-based micro-nano long fibers with nanometer diameters and loaded with magnetic nanoparticles and piezoelectric nanoparticles; (3) The long fibers are evenly dispersed in the solution, and short fibers with a length distribution within a certain range are prepared using micro-nano processing technology; (4) dispersing a certain mass of short fibers in a microsphere preparation solution; (5) using microsphere preparation technology to prepare the short fiber solution into magnetically controlled piezoelectric short fiber microspheres, and using a cross-linking method to separate the microspheres from the liquid phase; (6) The formed microspheres are filtered through a sieve, dispersed in a solution after washing, and a magnetronized piezoelectric short fiber microsphere scaffold is obtained.
2. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: The diameter of the biomaterial-based micro-nano long fiber is 10nm-500μm.
3. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: The magnetic nanoparticles in step (1) are one or more of Fe, Co, Ni monomers and their alloy nanoparticles, and metal oxide nanoparticles; the piezoelectric nanoparticles are one or more of ZnO, perovskite, BiOX, X=Cl, Br, I; and the concentration range of the nanoparticles is 0.1-200 mg / mL.
4. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: The surface modification method in step (1) is one or more of inorganic metal modification, organic small molecule modification, high molecular polymer modification, and silanization modification; the dopamine modification concentration is 2 mg / mL, and the chitosan modification concentration is 10-20 mg / mL.
5. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: The nanofiber preparation method described in step (2) is one or more of electrospinning technology, microfluidics technology, 3D printing technology, and near-field direct writing technology; wherein the electrospinning parameters are: flow rate of 5-25 μL / min, voltage of 10-25 kV, receiving distance of 10-20 cm, receiving mode of flat plate receiving or roller collection, roller receiving speed of 1000-2000 rpm, spinning time of 6-12 h; the microfluidics technology parameters are: propulsion speed of 1-300 μL / min; the 3D printing technology parameters are: print head temperature of 5-15 ° C, printing platform temperature set to -10 ° C, printing speed of 5-20 mm / s; the near-field direct writing parameters are: needle inner diameter of 0.5 mm, melt thrust of 0.2 MPa, fiber spacing of each sample set to 1.0 mm, receiving distance of 3-6 cm, receiving plate moving speed of 3-7 mm / s, melt temperature of 100-150 ° C.
6. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: The biomaterial in step (2) is one or more of natural biomaterial and synthetic biomaterial.
7. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: The solution in which the long fibers are dispersed in step (3) is one of PBS or physiological saline; the method for preparing the short fibers is one or more of grinding, homogenization, microscissor shearing, liquid nitrogen brittle breaking, and freeze-drying followed by pulverization; the short fiber length distribution range is 5-150 μm, and the fiber diameter distribution range is 20-500 nm, the length distribution range is determined according to the length of time of the short fiber preparation method, and the diameter distribution range is determined according to the flow rate, rotation speed, and voltage of the fiber preparation method.
8. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: In step (4), the microsphere preparation solution is one or more of N,N-dimethylformamide, hexafluoroisopropanol, formic acid, chloroform, acetic acid, gellan gum solution, sodium alginate solution and oil containing surfactant; in the microsphere collection method, the collection solution is Ca 2+ solution, formaldehyde, glutaraldehyde solution or more; the gellan gum solution concentration is 0.1-1% w / v, the sodium alginate solution concentration is 0.5-5g / mL, Ca 2+ The concentration is 0.1-1M, and the surfactant is one of Span and Tween.
9. The method for preparing a magnetically controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: The microsphere preparation technology in step (5) is one of spray drying, electrospraying, oil-in-water emulsification, microfluidics, freeze drying, emulsion-solvent evaporation, phase separation and reverse suspension crosslinking; the crosslinking method is one of ionic crosslinking, photocrosslinking and thermosensitive crosslinking; the diameter of the magnetron piezoelectric microspheres is distributed in the range of 10nm-500μm, and magnetron piezoelectric microspheres of different diameters are prepared according to actual needs.
10. The method for preparing a magnetron controlled piezoelectric short fiber oriented microsphere scaffold according to claim 1, characterized in that: In the microsphere washing method described in step (6), the washing liquid used is one or more of anhydrous ethanol, 75% ethanol, isopropanol, acetone, etc.; the external magnetic field driving source of the magnetron piezoelectric microspheres is a static magnetic field or an alternating magnetic field with a magnetic field intensity distribution ranging from low intensity to high intensity.
Citation Information
Patent Citations
Preparation method for drug-carrying multi-layer tissue engineering micro-nano structure bracket
CN103656754A
Controlled-release composite microsphere as well as preparation method and application thereof
CN117562872A
Passive sensing fiber compositions and composites thereof
US20220290349A1
Cited By
Magnetoelectric response fiber membrane as well as preparation method and application thereof
CN119800602A
